New academic research is casting aspersions on mutual funds’ benchmark selections and, by implication, on directors’ role in approving them. Directors rarely subject proposed benchmark changes to intense scrutiny, said Neil Bathon, founder and partner at FUSE Research Network.
For the complete article, click here (subscription required).
Article published on September 6, 2022